Deep TMS News & Events - Stay Updated with BrainsWay

News & Events

October 27, 2025

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

Recent agreements with two additional U.S. mental health providers bring total to four in 2025 Strategy...

October 28, 2025

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

September 16, 2025

BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)

Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard...

June 12 - June 14, 2025

Clinical TMS Society (CTMSS)

BrainsWay is attending the CTMSS conference June 13th through June 14th, in San Diego, CA. We invite...

May 9 - May 14, 2025

17th World Congress of International Neuromodulation Society

BrainsWay is attending the International Neuromodulation Society conference from May 9th through May...

May 28 - May 30, 2025

Psych Congress Elevate

BrainsWay is attending the Psych Congress Elevate Providers conference from May 28th through May 30th...

In the Media

October 1, 2025

Serenity Mental Health Centers Adopting SWIFT Deep TMS

Serenity Mental Health Centers, one of the leading providers of Deep TMS treatment nationwide, commits...

September 26, 2025

Coordinated transcranial magnetic stimulation, ketamine may benefit refractory depression

Coordinating transcranial magnetic stimulation (TMS) with ketamine therapy shows promising potential...

September 17, 2025

FDA clears accelerated protocol for BrainsWay Deep TMS in depression

BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial...